Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Electrophysiology Equipment analyzes the electrical activity of the heart. An Electrophysiology Ablation Catheter contains an electrode at one end that emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, thereby blocking further channeling of the impulses causing the heart’s abnormal rhythm. GlobalData uses proprietary data and analytics to provide a comprehensive report on the electrophysiology ablation catheters devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the electrophysiology ablation catheters market in New Zealand was Boston Scientific followed by Biosense Webster, Medtronic, Abbott Laboratories and Biotronik SE.
Electrophysiology Ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complications and recurrence. Standard and Advanced Electrophysiology Ablation Catheters are tracked under Electrophysiology Ablation Catheters. A Standard Electrophysiology Ablation Catheter contains a tip electrode through which radiofrequency energy is emitted. An Advanced Electrophysiology Ablation Catheter utilizes features and methods beyond those of Standard Ablation Catheters.
The value of the electrophysiology ablation catheters devices market within New Zealand was expected to be over $5m in 2023.
For the latest complete market share analysis of electrophysiology ablation catheters device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
